These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7831215)

  • 1. [Hormonal regulation in breast cancer from cell lines to patients].
    Rochefort H
    Presse Med; 1994 Sep 3-10; 23(26):1211-6. PubMed ID: 7831215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered expression of estrogen-regulated genes in a tamoxifen-resistant and ICI 164,384 and ICI 182,780 sensitive human breast cancer cell line, MCF-7/TAMR-1.
    Lykkesfeldt AE; Madsen MW; Briand P
    Cancer Res; 1994 Mar; 54(6):1587-95. PubMed ID: 8137264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of progesterone-binding breast cyst protein GCDFP-24 secretion by estrogens and androgens in human breast cancer cells: a new marker of steroid action in breast cancer.
    Simard J; Dauvois S; Haagensen DE; Lévesque C; Mérand Y; Labrie F
    Endocrinology; 1990 Jun; 126(6):3223-31. PubMed ID: 2351114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation, clinical and biological significance of cathepsin D in breast cancer.
    García M; Augereau P; Briozzo P; Capony F; Cavailles V; Freiss G; Maudelonde T; Montcourrier P; Vignon F; Rochefort H
    Rev Esp Fisiol; 1990 Mar; 46(1):39-41. PubMed ID: 2204091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines.
    Giamarchi C; Solanas M; Chailleux C; Augereau P; Vignon F; Rochefort H; Richard-Foy H
    Oncogene; 1999 Jan; 18(2):533-41. PubMed ID: 9927210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oestrogens, proteases and breast cancer. From cell lines to clinical applications.
    Rochefort H
    Eur J Cancer; 1994; 30A(10):1583-6. PubMed ID: 7833123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hormones and breast cancer in vitro.
    Dickson RB; Thompson EW; Lippman ME
    Hum Cell; 1989 Sep; 2(3):219-30. PubMed ID: 2519209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of estrogen independence of ZR-75-1 human breast cancer cells by epigenetic alterations.
    van Agthoven T; van Agthoven TL; Dekker A; Foekens JA; Dorssers LC
    Mol Endocrinol; 1994 Nov; 8(11):1474-83. PubMed ID: 7533260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines.
    Pink JJ; Jordan VC
    Cancer Res; 1996 May; 56(10):2321-30. PubMed ID: 8625307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A molecular strategy to control tamoxifen resistant breast cancer.
    Jiang SY; Jordan VC
    Cancer Surv; 1992; 14():55-70. PubMed ID: 1423331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term hydroxytamoxifen treatment of an MCF-7-derived breast cancer cell line irreversibly inhibits the expression of estrogenic genes through chromatin remodeling.
    Badia E; Duchesne MJ; Semlali A; Fuentes M; Giamarchi C; Richard-Foy H; Nicolas JC; Pons M
    Cancer Res; 2000 Aug; 60(15):4130-8. PubMed ID: 10945620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of ICI 164384 and beta-interferon on the growth and steroid receptor profile of breast cancer cell lines.
    Coradini D; Biffi A; Pirronello E; Di Fronzo G
    Anticancer Res; 1995; 15(6B):2557-61. PubMed ID: 8669823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiestrogenic effects of all-trans-retinoic acid and 1,25-dihydroxyvitamin D3 in breast cancer cells occur at the estrogen response element level but through different molecular mechanisms.
    Demirpence E; Balaguer P; Trousse F; Nicolas JC; Pons M; Gagne D
    Cancer Res; 1994 Mar; 54(6):1458-64. PubMed ID: 8137248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oestrogen- and anti-oestrogen-regulated genes in human breast cancer.
    Rochefort H
    Ciba Found Symp; 1995; 191():254-65; discussion 265-8. PubMed ID: 8582202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
    Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
    Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormonal regulation of synthesis and secretion of pS2 protein relevant to growth of human breast cancer cells (MCF-7).
    Kida N; Yoshimura T; Mori K; Hayashi K
    Cancer Res; 1989 Jul; 49(13):3494-8. PubMed ID: 2731170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal modulation of HER-2/neu protooncogene messenger ribonucleic acid and p185 protein expression in human breast cancer cell lines.
    Read LD; Keith D; Slamon DJ; Katzenellenbogen BS
    Cancer Res; 1990 Jul; 50(13):3947-51. PubMed ID: 1972345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression and hormonal regulation of pro-cathepsin D in mammary and endometrial cancer.
    Rochefort H; Cavailles V; Augereau P; Capony F; Maudelonde T; Touitou I; Garcia M
    J Steroid Biochem; 1989; 34(1-6):177-82. PubMed ID: 2626016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice.
    Osborne CK; Hobbs K; Clark GM
    Cancer Res; 1985 Feb; 45(2):584-90. PubMed ID: 3967234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.